Joris van de Haar

4.3k citations
28 papers · 3.1k · 5 hit papers · h-index 18

Impact in

  • Oncology top 2%
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Immunotherapy and Biomarkers 11
    • Colorectal Cancer Treatments and Studies 6
    • Cancer Cells and Metastasis 4
    • Cancer Treatment and Pharmacology 2
    • Cancer Genomics and Diagnostics 8

Joris van de Haar

27 papers receiving 3.0k citations

Joris van de Haar's Hit Papers

A pan-cancer analysis of the microbiome in metastatic cancer 2024 · 148 citations
1480+2+5Years since publication250500750

Peers

Joris van de Haar
Comparison fields: 5 of 111
  • Oncology 1.8k
  • Cancer Research 649
  • Immunology 547
  • Biotechnology 193
  • Biomedical Engineering 525
Replace David J. Watkins with:
David J. Watkins United Kingdom
Maria Antonietta Bali Belgium
Sing Yu Moorcraft United Kingdom
Vijayakrishna K. Gadi United States
Ronald Peter Zweemer Netherlands
Simon J. Dovedi United Kingdom
Hani M. Babiker United States
Catherine Dowling Ireland
Louisa Rose Hoes Netherlands
Matthew J. Adamow United States
Joris van de Haar relative to David J. Watkins United Kingdom David J. Watkins's profile →
Citations per field
00.5×1.5×1.9×
David J. Watkins · 1×
Citations per year

Countries citing papers authored by Joris van de Haar

Since Specialization
Citations

This map shows the geographic impact of Joris van de Haar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris van de Haar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris van de Haar more than expected).

Fields of papers citing papers by Joris van de Haar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris van de Haar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris van de Haar. The network helps show where Joris van de Haar may publish in the future.

Co-authors

The 25 scholars most cited alongside Joris van de Haar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joris van de Haar Line = papers co-authored together Joris van de Haar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Hit paper breakdown →
2018900
2
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Hit paper breakdown →
2019593
3 2017274
4 2020258
5
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
Hit paper breakdown →
2023218
6
A pan-cancer analysis of the microbiome in metastatic cancer
Hit paper breakdown →
2024148
7 2021104
8
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Hit paper breakdown →
202485
9 201967
10 202366
11 202364
12 202258
13 202154
14 201930
15 202430
16 202129
17 202526
18 202422
19 202515
20 20249

About Joris van de Haar

Joris van de Haar is a scholar working on Oncology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 28 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Cells and Metastasis (4 papers), Immunotherapy and Immune Responses (3 papers), Lung Cancer Treatments and Mutations (3 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (649 citations), Immunology (547 citations), Biotechnology (193 citations) and Biomedical Engineering (525 citations). Joris van de Haar has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Emile E. Voest, Trey Ideker, Lodewyk F.A. Wessels, Nicola de Prisco, Michael J. Slifker, Hannah Carter, Hatice Billur Engin, David Rossell, Saghar Kaabinejadian and Rachel Marty. Their work appears in journals such as Nature Medicine, Annals of Oncology, Cell, Clinical Cancer Research and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact